Assyro AI

Orange Book product · Generic (ANDA)

CARDIOPLEGIC IN PLASTIC CONTAINER

CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Generic (ANDA)ANDA 214623TE ATRX FRESENIUS KABI USA

At a glance

Feb 18, 2022

Approved

Generic (ANDA)

Application

AT

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 18, 2022

    4 yr 5 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Strength

17.6MG/100ML;325.3MG/100ML;119.3MG/100ML;643MG/100ML

Dosage form

SOLUTION

Route

PERFUSION, CARDIAC

TE code

AT

Application

ANDA 214623

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.